|
 GSK,
CureVac to develop vaccine against variants
Britain's GlaxoSmithKline and German biotech firm CureVac have
teamed up in a 150 million euro ($180 million) deal to develop a
vaccine from next year that could target several variants of the
coronavirus with one shot.
New, more contagious mutations have emerged in Britain, South Africa
and Brazil and while existing vaccines appear to offer some
protection against them, there are fears further changes in the
virus could evade the shots.
The German biotech firm is banking on messenger RNA, a cutting-edge
genetic technology that has allowed rivals to lead the vaccine
development race.
Recovered patients likely protected for at least six months
Almost all people previously infected with COVID-19 have high levels
of antibodies for at least six months that are likely to protect
them from reinfection with the disease, results of a major British
study showed on Wednesday.
Scientists said the study, which measured levels of previous
COVID-19 infection in populations across Britain, as well as how
long antibodies persisted in those infected, should provide some
reassurance that swift cases of reinfection will be rare.
New Zealand approves vaccine
New Zealand on Wednesday warned against "vaccine nationalism" that
could delay the rollout of international shipments after its
medicines regulator provisionally approved the use of the Pfizer-BioNTech
vaccine.
Prime Minister Jacinda Ardern said she expected supplies of the
Pfizer-BioNTech product to arrive by the end of March, but expressed
concern at any attempt to limit exports.
"The world just can't afford for that to happen. We won't be safe
until we have widespread rollout across the globe," she told a news
conference.
[to top of second column] |
Olympics face another looming headache
Japanese doctors and nurses will not have the time to volunteer to
help at the Olympics, a medical association has said, raising
another headache for organisers determined to hold the postponed
Games.
The director of the Tokyo Medical Association, which represents
20,000 doctors from dozens of smaller medical groups, said doctors
and nurses were under too much strain dealing with a third wave of
the pandemic to even consider signing up for the Olympics.
Thailand's Phuket plans private vaccination drive
Thailand's resort island of Phuket is planning private vaccinations
for 250,000 residents in the hope the government will allow it to
fully reopen to foreign tourists by October and save its battered
economy, industry officials said.
"The people of Phuket are losing hope," the president of the Phuket
Tourism Association, Bhummikitti Ruktaengam, said.
About 10.5 million of the nearly 40 million foreign visitors to
Thailand in 2019 visited Phuket.
'Hero' Captain Tom Moore dies aged 100
Britain's Captain Tom Moore, the World War Two veteran who lifted a
nation's spirits by raising millions of pounds for health service
workers battling the coronavirus, died on Tuesday aged 100 after he
contracted COVID-19.
Moore struck a chord with locked-down Britain by walking around his
garden with the help of a frame to raise 38.9 million pounds ($53
million) for the National Health Service.
(Compiled by Linda Noakes; Editing by Robert Birsel)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
